Johnson & Johnson vs PayPal Holdings, Inc. — how do they compare? Johnson & Johnson trades at $260.28 (market cap $626.09B), while PayPal Holdings, Inc. trades at $58.33 (market cap $50.47B). The key difference: Johnson & Johnson is far larger — about 12.4× PayPal Holdings, Inc.'s market cap, and Johnson & Johnson pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| JNJ | PYPL | |
|---|---|---|
Market Cap | $626.09B | $50.47B |
Volume | 6,156,228 | — |
Sector | Health | Financials |
52-Week High | $267.24 | $76.13 |
52-Week Low | $172.78 | $39.08 |
Enterprise Value | $654.37B | $52.62B |
Dividend Yield | 2.06% | 0.95% |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.81, up 0.99% on the day and near its 52-week high. The stock exhibits bullish technical signals with strong moving average support, while fundamentals show robust profitability with a net income margin of 21.48% and consistent dividend growth. Recent earnings have mostly beaten expectations, and the company maintains a solid balance sheet with $24.52 billion in cash.
The outlook for JNJ remains positive, supported by analyst consensus and a price target of $284.50. Key opportunities include its defensive healthcare positioning and pipeline strength, though risks involve patent expirations and legal headwinds. The stock offers a stable investment with growth potential in a volatile market.
PayPal trades at $59.07, showing stability with no recent price change. The stock exhibits bullish technical signals with strong moving average support and trades near key resistance at $60. Fundamentally, PayPal delivered Q2 2026 earnings beat with $1.38 EPS versus $1.28 expected, while revenue grew to $33.17 billion in 2025 with improving profit margins. Recent news highlights acquisition interest and strategic partnerships expanding payment capabilities.
PayPal presents a compelling value opportunity with attractive valuation multiples (P/E 11.15, P/S 1.6) and strong cash flow generation ($6.42B operating cash flow). However, risks include competitive pressures in digital payments and execution challenges under new leadership. Analyst consensus leans neutral with 60% hold ratings, though the $58.75 price target suggests limited upside from current levels.
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →